Event Calendar

Share This

April 2021

Mary Young, MD, Georgetown University will present "Use of Human Subjects" as a part of the Translational Biomedical Science (TBS) Responsible Conduct of Research (RCR) Series.

This month's Research Grand Rounds features Alejandra Hurtado de Mendoza, PhD, Assistant Professor at the Cancer Prevention and Control Program at Georgetown Lombardi Comprehensive Cancer Center. Dr. Hurtado de Mendoza will discuss "Adapting an evidence-based telephone genetic counseling intervention for Latina women at-risk of Hereditary Breast and Ovarian Cancer".

APR 13
Hepatic Macrophage and Stellate Cell Cross-Talk in Fibrogenesis  Apr 13, 2021   12: 00 PM - 1: 00 PM  Zoom

As a part of the Virginia Commonwealth University (VCU) Wright Center KL2 Visiting Scholar Seminar Series, GHUCCTS KL2 scholar Annie J. Kruger, MD, Ph.D., will give a keynote presentation titled "Hepatic Macrophage and Stellate Cell Cross-Talk in Fibrogenesis".

APR 14
2021 Spring CTSA Program Group Meetings  Apr 14, 2021  09: 00 AM - 5: 00 PM  Online

Registration is now open for the 2021 Spring CTSA Program Group Meetings, held April 14-15, 2021. These virtual meetings will feature groups discussing their respective accomplishments, future direction and goals.

APR 14
Master's in Clinical & Translational Research Info Session  Apr 14, 2021  1: 00 PM - 1: 30 PM  Zoom

Join this info session to learn more about the Georgetown University Master's in Clinical and Translation Research. Program staff will provide an overview of the Master's in Clinical and Translational Research Program, including the admissions process, careers in Clinical and Translational Research, and other frequently asked questions.

APR 15
Communicating Science: Engaging Policymakers  Apr 15, 2021  09: 30 AM - 10: 30 AM  Location

The American Association for the Advancement of Science (AAAS) Communicating Science Workshop's goals include building scientists' communication skills and confidence in engaging with public audiences and providing best practices for use of different communication methods and mechanisms. The one-hour Engaging Policymakers module illuminates the policy landscape, illustrating where and how policy happens and the many roles scientists andengineers can play in decision-making.

This month's MHRI-GHUCCTS Monthly Statistical Seminar Series features Dr. Paul Kolm, Associate Director in the Department of Biostatistics and Biomedical Informatics at MedStar Health Research Institute. Dr. Kolm will discuss "Health Care Economics: Cost-effectiveness Alongside Clinical Trials".

This Windows into Translation (WiT) seminar features Karl M. Thompson, Ph.D., Associate Professor, Department of Microbiology, Howard University. Dr. Thompson discusses "Functional Genomics to Discover Novel Protein Functions in S. Aureus".

APR 23

The topic for the first day of the conference on Friday, April 23, 2021, is “Moving Swiftly to Combat the COVID-19 Global Health Crisis”. Dr. David Diemert from The George Washington University School of Medicine & Health Sciences is our keynote speaker. Following the keynote speaker, we will facilitate panel discussions with local experts on vaccine research and rollout, diverse participant recruitment efforts, and the various regulatory issues related to human subject COVID-19 research.

APR 27
Learning from History: Safely Moving Women's Health Forward  Apr 27, 2021  6: 00 PM - 7: 00 PM  Zoom

GHUCCTS in the (Virtual) Community aims to promote clinical research awareness, diversity in research, and community-engaged research through virtual outreach efforts that will be held monthly. Our April session will cover "Learning from History: Safely Moving Women's Health Forward".

The topic for the second day of the conference on Friday, April 30, 2021, is “Beyond COVID-19: Challenges & Lessons Learned during a Pandemic”. Our keynote speaker is Dr. Stephen Hansen with the U.S. Food and Drug Administration. Following the keynote speaker, our panelists will explore the challenges faced by researchers during the pandemic, offering lessons learned to move clinical and translational science forward as we emerge from this experience